Bupathi, Manojkumar
Hajjar, Joud
Bean, Stacie
Fu, Siqing
Hong, David
Karp, Daniel
Stephen, Bettzy
Hess, Kenneth
Meric-Bernstam, Funda
Naing, Aung
Article History
Received: 23 June 2016
Accepted: 23 September 2016
First Online: 29 September 2016
Compliance with ethical standards
:
: JH serves as a consultant for Baxter; DH received honoraria for a talk and research funding from Lilly; DK received research funding from Phosplatin Pharma Inc.; FMB received honoraria from Genentech, Roche Diagnostics, and Sysmex, served as a consultant for Genentech, Novartis, Roche, and Inflection Biosciences, and received research funding from Novartis, Astra Zeneca, Taiho Pharmaceutical, Genentech, Calithera Biosciences, Debiopharm Group, and Bayer; MB, SB, SF, BS, KH, and AN have no conflict of interest to disclose.
: This work was supported by the NIH Clinical and Translational Science Award UL1 RR024148 and by the NIH Cancer Center Support Grant (CCSG) award CA016672 to MD Anderson Cancer Center
: The study was conducted with the approval of and in accordance with the guidelines of the MD Anderson Cancer Center Institutional Review Board.